Introduction

Outside of oncology, we hope to fully explore the potential of using Bicycles to tackle a variety of hard-to-drug targets in areas of high unmet medical need. We are collaborating with a wide range of pharma partners, leading academics, and public bodies to explore how we might develop innovative new medicines in respiratory, cardiovascular and metabolic disease, ophthalmology, anti-infective, dementia, central nervous system and neuromuscular therapy areas. These partnerships could enhance our future ability to bring this important class of medicines to patients with debilitating diseases, without distracting from our core mission to deliver new drugs for oncology.